|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S1
|
$121,550
|
$3,647
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S2
|
$60,000
|
$1,800
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S3
|
$125,625
|
$3,769
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S4
|
$200,000
|
$6,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S5
|
$484,876
|
$14,546
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S6
|
$502,500
|
$15,075
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
4P30CA016359-37
|
$2,600,006
|
$78,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-03
|
$551,500
|
$27,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
3U10CA180833-02S1
|
$100,000
|
$7,500
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-03
|
$1,649,280
|
$123,696
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
VIRUS DISCOVERY AND CHARACTERIZATION IN LARGE-SCALE CANCER SEQUENCING DATA
|
5R01CA178383-03
|
$255,216
|
$84,221
|
DING, LI
|
WASHINGTON UNIVERSITY
|
|
Viral Oncology Training Grant
|
5T32CA009111-38
|
$378,220
|
$75,644
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-03
|
$9,808
|
$490
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
6U10CA180847-04
|
$410,211
|
$20,511
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-42S1
|
$125,000
|
$2,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
4P30CA014520-42
|
$4,288,496
|
$85,770
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-03
|
$645,976
|
$32,299
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
3U10CA180870-02S1
|
$50,000
|
$2,500
|
SCHILLER, JOAN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-03
|
$1,192,600
|
$59,630
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Using comparative effectiveness analyses to optimize cervical cancer screening
|
4R01CA169093-04
|
$527,836
|
$527,836
|
SAWAYA, GEORGE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Using bacterial CRISPR/Cas endonucleases to selectively eliminate HPV-transformed cells in vivo
|
5R21CA198050-02
|
$172,913
|
$58,790
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
2P30CA014089-41
|
$6,354,897
|
$63,549
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S1
|
$59,999
|
$600
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S2
|
$37,500
|
$375
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
University of Colorado NTCN Lead Academic Participating Site (LAPS)
|
5U10CA180834-03
|
$768,950
|
$57,671
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses
|
2R01CA143130-06A1
|
$545,019
|
$545,019
|
NAKAGAWA, MAYUMI
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-Associated Cancer
|
5U54CA190153-03
|
$672,287
|
$262,192
|
MARTIN, JEFFREY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-03
|
$626,991
|
$15,675
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Tumor infiltrating lymphocyte therapy for human papillomavirus-positive cancers
|
ZIA BC 011478
|
$723,962
|
$347,502
|
Hinrichs, Christian
|
CCR (NCI)
|
|
Tumor gene expression in vitro and in vivo
|
ZIA BC 008905
|
$569,283
|
$170,785
|
Lowy, Douglas
|
CCR (NCI)
|
|
Translating Molecular Diagnostics for Cervical Cancer Prevention into Practice
|
1R01CA190366-01A1
|
$586,867
|
$586,867
|
GRAVITT, PATTI
|
GEORGE WASHINGTON UNIVERSITY
|
|
Training of Academic Gynecologic Oncologists
|
2T32CA101642-11
|
$466,239
|
$153,859
|
LU, KAREN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-32
|
$592,471
|
$195,515
|
PRESS, OLIVER
|
UNIVERSITY OF WASHINGTON
|
|
The Role of The Fanconi Anemia Pathway in Human Papillomavirus Infection
|
5F31CA192801-03
|
$35,330
|
$17,665
|
SPRIGGS, CHELSEY
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-22S1
|
$79,482
|
$3,179
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-22S2
|
$202,481
|
$8,099
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
4P30CA060553-22
|
$4,865,180
|
$194,607
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Radiation Planning Assistant (RPA) for Radiation Therapy Planning in Low- and Middle-Income Countries
|
1UH2CA202665-01
|
$491,512
|
$162,199
|
COURT, LAURENCE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The Lymphedema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors, and
|
4R01CA162139-05
|
$574,604
|
$195,365
|
BARAKAT, RICHARD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
The HPV Persistence and Progression Cohort (PaP Cohort)
|
ZIA CP010206-10383
|
$427,017
|
$427,017
|
Schiffman, Mark
|
DCEG (NCI)
|
|
Targeting HPV Consequences in a Cervical Cancer Clinical Trial
|
1R01CA200126-01A1
|
$595,072
|
$595,072
|
BENBROOK, DORIS
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
T-cell receptor gene therapy for human papillomavirus-positive cancers
|
ZIA BC 011479
|
$723,962
|
$506,773
|
Hinrichs, Christian
|
CCR (NCI)
|
|
SWOG Network Group Operations Center of the NCTN
|
3U10CA180888-03S1
|
$308,895
|
$15,445
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
SWOG Network Group Operations Center of the NCTN
|
5U10CA180888-03
|
$5,204,873
|
$260,244
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Surgery Branch Cell Prep Core
|
ZIC BC 010905
|
$803,454
|
$120,518
|
Wunderlich, John
|
CCR (NCI)
|
|
SUCCEED (Study to Understand Cervical Cancer Early Endpoints and Determinants)
|
ZIA CP010124-01105
|
$70,462
|
$70,462
|
Wentzensen, Nicolas
|
DCEG (NCI)
|
|
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors
|
ZIA BC 011109
|
$174,730
|
$5,242
|
Mitsuya, Hiroaki
|
CCR (NCI)
|
|
State Immunization Information Systems to Improve HPV Vaccination Rates
|
5R01CA187707-02
|
$590,968
|
$590,968
|
SZILAGYI, PETER
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Stanford University NCTN- Network Lead Academic Site
|
5U10CA180816-03
|
$490,000
|
$24,500
|
WAKELEE, HEATHER
|
STANFORD UNIVERSITY
|
|
SPORE in Cervical Cancer
|
5P50CA098252-13
|
$2,152,942
|
$2,152,942
|
WU, TZYY-CHOOU
|
JOHNS HOPKINS UNIVERSITY
|
Total relevant funding to Cervical Cancer for this search: $65,573,557
|